Interaction between quinolones and caffeine
- PMID: 3481318
- DOI: 10.2165/00003495-198700341-00035
Interaction between quinolones and caffeine
Abstract
The effects of multiple doses of ofloxacin 200 mg, ciprofloxacin 250 mg or enoxacin 400 mg (all twice daily) on the pharmacokinetic properties of single doses of caffeine (220 to 230 mg) were investigated in 12 healthy volunteers. Intraindividual comparisons showed that ciprofloxacin and enoxacin significantly inhibited the elimination of caffeine. Ofloxacin, however, did not affect any of the measured pharmacokinetic properties of caffeine. Thus, caffeine should be avoided in patients with liver disorders, cardiac arrhythmias, latent epilepsy or in intensive care while undergoing treatment with enoxacin or ciprofloxacin.
Similar articles
-
Decrease of caffeine elimination in man during co-administration of 4-quinolones.J Antimicrob Chemother. 1987 Nov;20(5):729-34. doi: 10.1093/jac/20.5.729. J Antimicrob Chemother. 1987. PMID: 3480885
-
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].Pathol Biol (Paris). 1988 May;36(5):496-9. Pathol Biol (Paris). 1988. PMID: 3136430 French.
-
Gyrase-inhibitors impair caffeine elimination in man.Methods Find Exp Clin Pharmacol. 1987 Mar;9(3):193-8. Methods Find Exp Clin Pharmacol. 1987. PMID: 3037212 No abstract available.
-
Quinolones.Prog Drug Res. 1987;31:243-56. doi: 10.1007/978-3-0348-9289-6_7. Prog Drug Res. 1987. PMID: 3326031 Review. No abstract available.
-
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.Infection. 1988;16(1):8-12. doi: 10.1007/BF01646921. Infection. 1988. PMID: 3283041 Review.
Cited by
-
Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.Antimicrob Agents Chemother. 1990 Nov;34(11):2148-51. doi: 10.1128/AAC.34.11.2148. Antimicrob Agents Chemother. 1990. PMID: 2073104 Free PMC article.
-
In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.Antimicrob Agents Chemother. 1999 May;43(5):1091-7. doi: 10.1128/AAC.43.5.1091. Antimicrob Agents Chemother. 1999. PMID: 10223919 Free PMC article.
-
Use of therapeutic caffeine in acute care postoperative and critical care settings: a scoping review.BMC Anesthesiol. 2021 Mar 31;21(1):100. doi: 10.1186/s12871-021-01320-x. BMC Anesthesiol. 2021. PMID: 33789583 Free PMC article.
-
Ofloxacin clinical pharmacokinetics.Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004. Clin Pharmacokinet. 1992. PMID: 1559306 Review.
-
Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin.Korean J Physiol Pharmacol. 2017 Jan;21(1):107-115. doi: 10.4196/kjpp.2017.21.1.107. Epub 2016 Dec 21. Korean J Physiol Pharmacol. 2017. PMID: 28066147 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical